Dr. Lal PathLabs LtdHealthcare Service ProviderINE600L01024Consolidated₹1896.90-27.80 (-1.44%)Jun-26
Valuation
Market Cap₹31.80K Cr
TTM PE58.46x
Forward PE60.72x
PEG2.50
Book Value₹149.62
P/B12.68x
TTM EPS₹32.45
Fwd EPS₹31.24
TTM Revenue₹2.89K Cr
TTM PAT₹546.30 Cr
TTM EBITDA₹837.70 Cr
TTM EBIT₹666.10 Cr
Last Qtr PAT₹170.50 Cr
Last Qtr EBITDA₹247.50 Cr
Last Qtr EBIT₹203.10 Cr
Profitability
ROE21.78%
ROCE27.38%
TTM NPM18.90%
TTM EBITDA %28.98%
Curr OPM20.55%
Last OPM18.19%
Curr NPM
Last NPM
Curr EPS₹10.15
Last EPS₹7.86
Balance sheet
Equity₹167.60 Cr
Reserve₹2.34K Cr
Total Debt₹199.00 Cr
D/E0.08x
Interest %3.70%
Curr Interest₹6.30 Cr
Price / range
Close₹1896.90
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D-1.44%
1W-0.63%
1M-0.24%
3M+14.07%
6M+40.74%
1Y+15.47%
2Y+17.21%
3Y+60.73%
5Y-4.71%
Diwali+25.71%
Sector peers — Healthcare Service Provider
CompanyCloseMkt CapTTM P/EROE
LALPATHLAB1896.90₹31.80K Cr58.4621.78%
VIJAYA1558.90₹16.04K Cr85.5119.59%
METROPOLIS597.45₹12.39K Cr61.4013.40%
THYROCARE555.80₹8.85K Cr50.3930.04%
NEPHROPLUS743.35₹7.46K Cr87.666.88%
KRSNAA541.15₹1.76K Cr18.009.94%
SURAKSHA335.10₹1.75K Cr48.7114.33%
3BBLACKBIO1326.95₹1.14K Cr19.5621.67%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue764.40+19.3%675.20632.10699.60640.702,647.60
Other Income29.903726.6022.8026.30112.70
Total Income794.30+19.1%712.20658.70722.406672,760.30
Interest6.105.9074.604.5022
Expenditure-572-15.6%-542.30-505.50-527.60-494.60-2,070
PBDT000000
EBITDA238.50+30.0%181.50173.70215.10183.40753.70
Depreciation-40-42.70-40.10-38.50-32.80-154.10
EBIT198.50+31.8%138.80133.60176.60150.60599.60
PBT222.30+28.9%169.90123.10194.80172.40660.20
Tax-56.40-28.80-31-49.10-43.10-152
Equity167.60167.60167.60083.80167.60
OPM27.9923.8618.6927.8425.8523.92
Net Profit165.90+28.3%141.1092.10145.70129.30508.20
NPM20.8919.8113.9820.8319.3918.41
EPS9.94-35.9%8.455.5217.4615.5130.45

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,647.60+12.6%2,351.60+19.6%1,966.80+11.2%1,769-5.5%1,872.70+25.6%1,490.50
Other Income112.70111.5060.1046.605351.30
Total Income2,760.30+12.1%2,463.10+21.5%2,026.90+11.6%1,815.60-5.7%1,925.70+24.9%1,541.80
Expenditure-2,070-12.4%-1,841.80-21.9%-1,510.90-6.0%-1,424.80+2.8%-1,466.30-25.6%-1,167.70
Interest-22-21.50-26.80-34.40-28.50-14.80
PBDT000000
EBITDA753.70+13.3%665.50+19.0%559.20+21.4%460.70-9.7%510.20+25.2%407.40
Depreciation-154.10-134.20-76.50-82.10-75.30-69.80
EBIT599.60+12.9%531.30+10.1%482.70+27.5%378.60-12.9%434.90+28.8%337.60
PBT660.20+6.3%621.30+20.4%516+32.0%390.80-14.9%459.40+22.8%374.10
Tax-152-124-131.60-98.40-115.30-94
Equity167.6083.600000
OPM (%)23.9225.2225.0022.0024.0024.00
Net Profit508.20+2.2%497.30+29.4%384.40+31.5%292.40-15.0%344.10+22.8%280.10
NPM (%)18.4120.1919.0016.0018.0018.00
EPS (Rs)30.45-49.0%59.70+29.1%46.25+31.1%35.28-15.2%41.61+22.6%33.93
CEPS30.4059.6146.1835.1741.4833.85

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue797.70+19.1%702.70659.80730.60669.802,762.90
Other Income31.902424.4024.8028.10101.30
Total Income829.60+18.9%726.70684.20755.40697.902,864.20
Interest6.306.107.204.804.7022.80
Expenditure-600.90-16.3%-566.60-529.80-551.80-516.80-2,165
PBDT000000
EBITDA247.50+28.7%186.80179.30224.10192.30782.50
Depreciation-44.40-44.60-42.10-40.50-34.60-161.80
EBIT203.10+28.8%142.20137.20183.60157.70620.70
PBT228.70+26.3%160.10124.30203.60181.10669.10
Tax-58.20-27.90-32.90-51.40-47.10-159.30
Equity167.60167.60167.60083.80167.60
OPM27.5722.0318.1726.9525.9523.36
Net Profit170.50+27.2%132.2091.40152.20134509.80
NPM20.5518.1913.3620.1519.2017.80
EPS10.157.865.4218.05030.24

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,762.90+12.2%2,461.40+10.5%2,226.60+10.4%2,016.90-3.4%2,087.40+32.0%1,581.30
Other Income101.3093.4069.2041.7052.5051.30
Total Income2,864.20+12.1%2,554.80+11.3%2,295.80+11.5%2,058.60-3.8%2,139.90+31.1%1,632.60
Expenditure-2,165-12.2%-1,930.10-7.8%-1,790.30-4.4%-1,714.70-3.0%-1,665-34.5%-1,238.20
Interest-22.80-22.30-29.40-37.50-30.20-16
PBDT000000
EBITDA782.50+12.5%695.50+14.1%609.30+24.4%489.90-12.6%560.70+28.5%436.30
Depreciation-161.80-141.90-143.60-150.20-108.10-77.20
EBIT620.70+12.1%553.60+18.9%465.70+37.1%339.70-24.9%452.60+26.0%359.10
PBT669.10+7.1%624.70+23.6%505.50+47.0%343.90-27.6%474.90+20.4%394.40
Tax-159.30-132.50-143.20-102.80-124.60-97.90
Equity167.6083.600000
OPM (%)23.3624.4522.0216.7122.1924.16
Net Profit509.80+3.6%492.20+35.9%362.30+50.3%241.10-31.2%350.30+18.1%296.50
NPM (%)17.8019.2715.7811.7116.3718.16
EPS (Rs)30.24-48.3%58.48+35.8%43.05+49.4%28.82-30.9%41.70+18.0%35.33
CEPS30.2058.4042.9828.7441.5735.25

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

28
YearTypeAmountEx-Date
2027Interim Dividend530 Jul 2026
2026Final Dividend425 Jun 2026
2026Interim Dividend3.505 Feb 2026
2026Interim Dividend707 Nov 2025
2026Interim Dividend606 Aug 2025
2025Final Dividend606 Jun 2025
2025Interim Dividend605 Feb 2025
2025Interim Dividend605 Nov 2024
2025Interim Dividend620 Aug 2024
2024Final Dividend610 Jun 2024
2024Interim Dividend1213 Feb 2024
2023Final Dividend611 Aug 2023
2024Interim Dividend611 Aug 2023
2023Interim Dividend605 Aug 2022
2022Final Dividend622 Jun 2022
2022Interim Dividend618 Aug 2021
2021Final Dividend820 Jul 2021
2021Interim Dividend609 Feb 2021
2021Interim Dividend618 Nov 2020
2020Interim Dividend605 Mar 2020
2020Interim Dividend620 Nov 2019
2019Final Dividend3.502 Aug 2019
2019Interim Dividend2.519 Nov 2018
2018Final Dividend303 Aug 2018
2018Interim Dividend1.520 Nov 2017
2017Final Dividend1.712 Jul 2017
2017Interim Dividend1.313 Feb 2017
2016Final Dividend2.4520 Jul 2016

Bonus

1
YearRatioEx-Date
20251:119 Dec 2025

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers